专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20080300444A1 OPHTHALMIC APPLICATOR FOR TREATMENT OF PTERYGIUM OR GLAUCOMA USING 32P ALONE OR IN COMBINATION WITH 103Pd 审中-公开
标题翻译：使用32P单独或与103Pd组合治疗黄疸或葡萄球菌的眼科应用者
公开(公告)号：US20080300444A1
公开(公告)日：2008-12-04
申请号：US12126346
申请日：2008-05-23
申请人： Sung-Joon Ye , IlHan Kim , Won Ryang Wee , Mee Kum Kim , Kwang Jae Son , Hyon Soo Han , Ul Jae Park , Hyeon Young Shin
发明人： Sung-Joon Ye , IlHan Kim , Won Ryang Wee , Mee Kum Kim , Kwang Jae Son , Hyon Soo Han , Ul Jae Park , Hyeon Young Shin
IPC分类号： A61M36/04
CPC分类号： A61N5/1001 , A61N2005/1089
摘要： Disclosed is an ophthalmic applicator for the treatment of pterygium or or glaucoma using a radioisotope. It comprises a source volume for containing the radioisotope therein; a filter volume for controlling a radiation dose emitted from the radioisotope; and an encapsulation volume for encompassing the source volume and the filter volume, wherein the radioisotope is pure 32P or a combination of 32P and 103Pd. Ensuring the formation of more ideal dose distributions than do the conventional 90Sr ophthalmic applicators, as described hitherto, the ophthalmic applicator for the treatment of pterygium or glaucoma using 32P or a combination of 32P and 103Pd can promise both high therapeutic effects on pterygium or glaucoma and high safety effects on the eye lens. Further, 32P and 103Pd are easier to produce and treat than is 90Sr, thereby allowing the radiotherapy to be useful.
摘要翻译：公开了一种用于使用放射性同位素治疗翼状ium肉或青光眼的眼科施放器。它包括用于在其中容纳放射性同位素的源体积; 用于控制从放射性同位素发射的辐射剂量的过滤器体积; 以及用于包围源体积和过滤器体积的封装体积，其中放射性同位素是纯32P或32P和103Pd的组合。如上所述，确保形成更理想的剂量分布，如迄今所述，用于使用32P或32P和103Pd的组合治疗翼状ium肉或青光眼的眼科施用器可以对翼状ium肉或青光眼有很高的治疗效果，对眼睛镜片的高安全性影响。此外，32P和103Pd比90Sr更容易产生和治疗，从而允许放射治疗是有用的。

2. 发明授权

US06254637B1 Artificial cornea and implantation thereof 失效
标题翻译：人造角膜及其植入
公开(公告)号：US06254637B1
公开(公告)日：2001-07-03
申请号：US09546329
申请日：2000-04-10
申请人： Jin Hak Lee , Won Ryang Wee , Moo Suk Lee
发明人： Jin Hak Lee , Won Ryang Wee , Moo Suk Lee
IPC分类号： A61F214
CPC分类号： A61F2/142
摘要： An artificial cornea capable of preventing a separation thereof from an eyeball of the patient during an implant operation thereof while avoiding post-operative complications at the interface between the artificial cornea and the patient's cornea, such as erosive tissue necrosis (melting), leakage of aqueous humor, infection, extrusion of the implant, and intraocular inflammation. The artificial cornea includes an artificial cornea body having, at a lower portion thereof, a cylindrical portion adapted to be arranged in the interior of a patient's eyeball, and, at an upper portion thereof, an optical portion adapted to be exposed through an anterior portion of the patient's eyeball, the optical portion having a diameter less than that of the cylindrical portion to define a step at a lower end thereof, a skirt fitted around the optical portion of the cornea body and seated on the step, an anterior flange coupled to an upper surface of the skirt, and a support member attached to a lower end of the cylindrical portion and adapted to support the artificial cornea body. An amnion is covered on the implant in order to promote a stable graft of the artificial cornea to the patient's cornea during an initial reaction period for the recovery of a cut portion of the patient's cornea.
摘要翻译：一种人造角膜，其能够在其植入操作期间防止其与患者的眼球分离，同时避免在人造角膜和患者角膜之间的界面处的手术后并发症，例如侵蚀性组织坏死（熔化），水分泄漏幽默，感染，植入物的挤出和眼内炎症。人造角膜包括人造角膜体，其下部具有适于布置在患者眼球内部的圆柱形部分，并且在其上部具有适于通过前部暴露的光学部分患者眼球的光学部分的直径小于圆柱形部分的直径，以限定其下端的台阶，围绕角膜体的光学部分安装并位于台阶上的裙部，前凸缘连接到所述裙部的上表面和附接到所述圆筒形部分的下端并适于支撑所述人造角膜体的支撑构件。植入物覆盖羊膜，以便在用于恢复患者角膜切割部分的初始反应期间促进人造角膜对患者角膜的稳定移植。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式